Clinical Trial Update: A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Strontium-89 with or without Cisplatin for palliation of bone pain in hormone-refractory prostate cancer with bone metastases has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Prostate Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Strontium-89 chloride (Strontium-89 chloride)

Snippet

Sponsor: Alberta Health services | Conditions: Hormone Refractory Prostate Cancer, Bone Metastases | Phase 2 | Status: COMPLETED